Tumour immunology: NLRC3 inhibits mTOR in colorectal cancer

Nature Reviews Immunology 17, 79 (2017). doi:10.1038/nri.2016.152 Author: Olive Leavy NLRC3 protects against colorectal cancer by suppressing the proliferation of intestinal epithelial cells through inhibition of the PI3K–AKT–mTOR pathway.

http://feeds.nature.com/~r/nri/rss/current/~3/Lqr1G24y0v8/nri.2016.152

Source: Nature Reviews Immunology - January 2, 2017 Category: Allergy & Immunology Authors: Olive Leavy Tags: Research Highlight Source Type: research

More News: Allergy & Immunology | Cancer | Cancer & Oncology | Colorectal Cancer | Epithelial Cancer